Pharma Training That Passes Audits

Train medical reps, MSLs, and compliance teams with AI simulations that generate auditable evidence. RDC 658, FDA 21 CFR Part 211.25, and ICH Q9 ready.

Request Demo See plans

480

Reps in typical sales force deployments

100%

Sessions documented with auditable evidence

50+

Engagement badges

23

Languages supported

40%

Reduction in new rep ramp-up time

<24h

To retrain teams after regulatory changes

Real challenges

What blocks training today

What we hear from training leaders in real conversations. No fluff.

Theory does not translate to field execution

Pharma sales forces of 400 to 500 reps run training cycles every 3 months, but the real gap is field execution. The District Manager rides along, watches the rep miss, gives feedback in the car between consults, and loses most of that information by the next cycle. In Roleplays, every simulated visit generates a structured per-criterion record, giving the manager a continuous evolution trail per rep instead of isolated impressions.

In-person training costs are unsustainable

According to ATD (Association for Talent Development), average training cost per employee in pharma exceeds US$ 2,400 per year, not counting travel, per diems, and lost productive hours. For a sales force of 480 reps, that approaches US$ 1.2 million per year on in-person training alone. With Roleplays, reps practice from anywhere, as many times as they need, eliminating logistics costs.

Reps fail on methodological objections

Pharma sales is indirect: the rep needs to influence prescription using storytelling and discovery questions, not direct closing. When the doctor probes endpoints (3-component MACE, hazard ratio, confidence interval), distinguishes pre-specified from post-hoc analysis, or asks about CVOT subgroup populations, unprepared reps freeze or misquote data, losing clinical credibility instantly. Roleplays lets you train these exchanges with the AI playing the skeptical experienced physician. When a rep scores below the bar on a competency, the platform can auto-generate a follow-up roleplay aimed at the exact moment they missed, so they drill it until the response is calibrated.

Manual audit trail does not survive inspections

According to FDA data, 18% of Form 483 observations issued between 2020 and 2024 are related to training and documentation failures. Spreadsheets, sign-in sheets, and paper forms do not meet the required standards. Roleplays automatically records every session with timestamp, participant ID, full transcript, a 0 to 100 score per criterion with a supporting quote from the transcript, and a log of every AI call (tokens, cost, latency), all exportable in audit-ready format.

New reps take months to reach productivity

Pharma industry studies indicate that average rep ramp-up takes 9 to 12 months to reach quota. According to CSO Insights, only 57% of reps hit their annual quota. With AI simulations, new reps practice dozens of medical visits in days, accelerating ramp-up and increasing quota attainment.

Visual aids are presented without clinical mastery

A ZS Associates survey showed that 63% of physicians believe reps do not adequately know the clinical data they present. This drives credibility loss and compliance violation risk. In Roleplays, the AI evaluates the clinical accuracy of every rep statement, slide by slide, comparing against the approved label.

No objective quality metrics for training

Most pharma companies measure only attendance (completion rate), not actual competency. A McKinsey study showed that companies implementing competency-based assessment have 32% more reps hitting quota. Roleplays evaluates each interaction against a competency framework locked when the session starts, generating scores comparable across reps, teams, and regions, with stable criteria session after session.

Regulatory updates demand immediate retraining

When ANVISA updates RDC 658 or the FDA issues new guidelines, every rep needs to be retrained and evaluated quickly. Traditional methods take weeks to coordinate in-person sessions. With Roleplays, you update the scenario in minutes, launch to the whole sales force, and monitor progress in real time, with documented evidence that each person completed the retraining.

How Roleplays solves it

For every pain, a concrete answer

Segment-specific features mapped to each pain point above.

01

Video roleplay for medical visit realism (coming soon)

On the roadmap (coming soon), and the most requested scenario from pharma sales directors: video simulation with a doctor avatar, facial expression and speech cadence reading, reproducing the real environment of a 10-minute medical visit at the consultation room. Ideal for in-person medical visit teams in large hospital networks.

02

HCP voice persona simulation

AI-powered doctors, pharmacists, and nurses using real-time voice infrastructure, with configurable specialties, skepticism levels, and objection patterns. Available in text and voice modes today, with video on the roadmap (coming soon) for teams that need to faithfully reproduce the real medical-visit environment.

03

Filler words and hedging language metric

In voice simulations, the AI detects filler words ("um", "like", "you know"), hedging language ("I think", "maybe", "if I remember correctly"), and speech cadence, flagging when the rep transmits insecurity that the physician decodes as lack of product mastery. Reported per session and as time series per rep, useful for the District Manager to prioritize individual coaching.

04

Label compliance scoring

Label adherence is scored 0 to 100 with the offending line quoted straight from the transcript as evidence. Off-label claims, misquoted efficacy data, or omitted safety information are caught here, and because this criterion is marked critical, a serious deviation fails the whole session on its own regardless of the other scores.

05

Visual aid training mode

Simulate complete medical visits with visual aid presentation. The AI scores clinical accuracy per criterion, with a quote from the transcript backing each score, verifying that the rep communicates data correctly and within the boundaries approved by Medical Affairs and Compliance.

06

Audit-ready reports

Export complete training records per rep: sessions, scores, criteria met, timestamps, transcripts. Format ready for ANVISA, FDA, and internal audits. Filters by period, product, therapeutic area, and team.

07

Regulation-linked templates

Pre-built scenarios linked to specific regulatory requirements (RDC 658, FDA 21 CFR, ICH Q9/Q10). Each scenario automatically maps evaluation criteria to the regulation, ensuring compliance by design.

08

Multi-product launch readiness

Ramp entire sales forces on new products in days, not weeks. Parallel training across therapeutic areas with scenarios specific to medical specialty. Ideal for simultaneous launches across multiple markets.

09

Media library for contextual training

Upload labels, visual aids, clinical studies, and internal guidelines. The AI uses these documents as a knowledge base to evaluate rep responses accurately, ensuring every simulation is aligned with approved content.

10

Gamification with 50+ badges and leaderboards

Gamification system with 50+ achievement badges, team and regional leaderboards, and progression tracks. Reps receive recognition for product mastery, practice consistency, and compliance excellence, driving up to 3x more engagement than traditional methods.

11

Multi-language for global teams

Train the same simulation in 23 languages, including Portuguese, English, Spanish, Mandarin, Japanese, and Arabic. Essential for multinational pharma needing consistent quality and compliance across subsidiaries, with comparable metrics across countries.

See a real session

One conversation.
One rubric.

An example roleplay in this context. Each turn is scored against your tenant competency framework.

Scenario

Medical visit to present a new GLP-1 agonist for Type 2 Diabetes. The physician is highly experienced, with more than 15 years of practice, has limited time, and is skeptical about cardiovascular safety data.

Rubric criteria

Label complianceClinical data accuracyMethodological objection handlingEthical communicationClosing techniqueMethodological rigor on citationsFiller words and hedging
DH

Dr. Helena Nakamura

Endocrinologist, University Hospital of São Paulo

in session
Good morning. Look, I will be direct: I have 10 minutes max before my next patient. You wanted to discuss the new GLP-1 agonist, right? I have been prescribing liraglutide and semaglutide for years, so I need to understand what this brings beyond what I already have in my arsenal.
Good morning, Dr. Nakamura. Thank you for your time. Our pivotal phase III trial, SUSTAIN-CV, with 4,200 patients, showed an average HbA1c reduction of 1.8 percentage points versus placebo over 56 weeks, with a gastrointestinal tolerability profile comparable to semaglutide. But the key differentiator I want to highlight is in the cardiovascular data.
1.8% HbA1c reduction is within expectations for this class. No surprise. Now, when you mention cardiovascular data, I need detail. The LEADER trial for liraglutide took 5 years and over 9,000 patients to demonstrate CV benefit. What is the MACE data from your trial? And was the primary endpoint non-inferiority or superiority?
Excellent point, Doctor. The primary endpoint of our CVOT was non-inferiority for 3-component MACE, which was met with a comfortable margin. The observed hazard ratio was 0.74 with a 95% confidence interval of 0.58 to 0.95, and that superiority result for MACE was pre-specified as a hierarchical secondary endpoint, not a post-hoc analysis. The independent event adjudication committee was led by Dr. Verma from the TIMI Study Group.
HR of 0.74 with a 95% CI not crossing 1.0 and superiority pre-specified as hierarchical secondary, that is methodologically solid. But I worry about generalization: what was the baseline cardiovascular risk profile of the patients in the trial? Because if the population was predominantly high CV risk, the benefit may not hold for intermediate-risk patients. And what was the incidence of pancreatitis and thyroid neoplasia?
Type your reply...

Compliance & framework

Evidence that survives audit

Every session generates exportable evidence with timestamps and per-criterion scores. Audit ready.

RDC 658 / ANVISA

Good Manufacturing Practices training with documented evidence for ANVISA audits. RDC 658 requires training records for all manufacturing personnel, and Roleplays generates these records automatically.

FDA 21 CFR Part 211.25

Personnel training requirements with verifiable records of each session. Satisfies the requirement that each individual has documented training in cGMP and role-specific functions.

ICH Q9 / Q10

Quality risk management training and pharmaceutical quality system compliance. Scenarios simulate risk identification, assessment, and control according to ICH guidelines.

LGPD

Patient and HCP data handling training with privacy-by-design architecture. Full data isolation per company and encryption in transit and at rest.

FAQ

Frequently asked questions

Questions that come up in almost every first conversation.

How does Roleplays help with ANVISA audits?
Every training session is recorded with timestamp, participant ID, scenario details, evaluation scores, and AI feedback. Reports can be exported in audit-ready format, showing exactly what each rep was trained on, when, and how they performed. Reports include the full simulation transcript, the criteria evaluated, the 0 to 100 score per criterion with the supporting quote from the transcript, and the strengths, gaps, and recommendations returned by the evaluation, against a competency framework locked when the session starts. Every AI call is logged with tokens, cost, and latency. This eliminates dependency on manual forms and sign-in sheets.
Can we create scenarios for specific therapeutic areas?
Yes. You can create HCP personas by specialty (cardiologist, endocrinologist, dermatologist, oncologist, etc.), set difficulty levels, and define evaluation criteria specific to each drug or therapeutic area. You can also upload labels, visual aids, and clinical studies so the AI uses these as reference during evaluation. Companies with broad portfolios can maintain scenario libraries organized by product line.
How does label compliance scoring work?
The system scores every rep statement against approved label information on a 0 to 100 scale, quoting the exact line from the transcript that earned the score. If the rep makes an off-label claim, misquotes efficacy data, or omits safety information, the score drops and the offending quote is shown. Because compliance can be set as a critical criterion, a serious deviation fails the session on its own regardless of the other scores, and the rep can retry the failed attempt.
Do you offer video roleplay to reproduce in-person visits?
Video roleplay with a doctor avatar is on the roadmap (coming soon), not available yet. When it ships, it will reproduce facial expression, speech cadence, and the environment of a 10-minute consultation visit, the highest-fidelity scenario for in-person medical visit teams in large hospital networks. Today, chat and real-time voice roleplay are available. Talk to us if video fidelity is a priority for your team.
How does the AI detect filler words and hedging from reps?
In voice simulations, the AI processes the transcript and audio to identify filler words ("um", "like", "you know"), hedging language ("I think", "maybe", "I believe so"), and speech cadence. Each simulation returns a count of these markers, and the dashboard aggregates them into time series per rep. Sales directors use this metric to identify who transmits clinical insecurity, even when the content of the answer is technically correct, and prioritize individual coaching. A metric frequently requested by pharma teams in sales forces of 400 to 500 reps.
Can we train reps in multiple languages?
Yes. Roleplays supports 23 languages, including Portuguese, English, Spanish, Mandarin, Japanese, and Arabic. You can train the same scenario in different languages, essential for multinational pharma companies that need to maintain message consistency and compliance across subsidiaries. Evaluation metrics are comparable across languages, enabling global benchmarking.
What about security of patient and HCP data?
Roleplays uses a dedicated database per company. Your data is fully separated from other customers. We are LGPD compliant and in the SOC 2 certification process. All communication is encrypted in transit (TLS 1.3) and at rest (AES-256). We do not store real patient data, simulations use fictitious AI-generated personas.
How does Roleplays compare to traditional in-person role-play training?
In-person role-play training is limited by logistics cost, trainer availability, and evaluation subjectivity. A human trainer evaluates at most 6 to 8 role-plays per day; Roleplays processes thousands simultaneously. Beyond that, AI evaluation against frozen criteria at dispatch removes the bias of a single subjective human evaluator. Reps can practice as many times as they want, anytime, at no incremental cost, and every session generates comparable data for performance analysis.
What is the implementation timeline for a sales force of 400 to 500 reps?
Typical implementation takes 2 to 4 weeks. In week 1, we set up scenarios and upload reference materials (labels, visual aids, guidelines). In week 2, we run a pilot with 20 to 30 reps to calibrate criteria and adjust personas. In weeks 3 and 4, we roll out fully and train District Managers on the analytics dashboard. We offer dedicated support throughout onboarding.
Can Roleplays integrate with our LMS?
Yes. Roleplays offers REST API integrations and SCORM/xAPI standards support, allowing sessions and scores to be automatically recorded in your LMS. We also expose webhooks for training-completion notification and report export in formats compatible with quality management systems (QMS) used in the pharma industry.
How does gamification work to keep reps engaged?
Roleplays includes more than 50 achievement badges recognizing different competencies: product mastery, objection handling, compliance, practice consistency, and more. There are leaderboards by team, region, and country, plus progression tracks by therapeutic area. Internal data shows that reps at companies with gamification enabled complete 3x more simulations per month than those without, resulting in better preparation for real visits.
Back to overview

Ready to transform how your team trains?

For organizations with 50+ employees. Book 45 minutes and we'll think the setup through with you.

Request Demo Talk to Sales